Specifically, the GFP-LC3 expressing ES-2 ovarian cancer cell line was treated with b-AP15 (5 μM), Vorinostat (20 μM) or combination of both for 18 hours and the sub-cellular localization of LC3, was visualized by immunofluorescence. The gene discussed is MAP1LC3A; the disease is ovarian carcinoma.